View Full Team

Terry
Gould

Partner & Head of Growth Equity Investments

Terry invests in venture and growth-oriented companies with a focus on the healthcare space. Terry sits on the Board of Directors of Aptinyx, Atox Bio, Corvus, Fusion Pharmaceuticals, Orbus, Outpost Medicine, Partner Therapeutics, and Qpex. He is a Board Observer at Millendo. He is a former Board Member at CombiChem, INC Research, Incline Therapeutics, and Proteus Digital Health. He is responsible for several other successful investments including Heartport, Jazz Pharmaceuticals, Naurex Pharmaceuticals, NxStage Medical, Pharmacyclics, Rempex Pharmaceuticals, Revivant, Spinal Dynamics, and Vivant Medical.

Terry is Chairman of the Adams Street Partners Growth Equity Investment Committee, as well as a member of the firm's Co-Investment Committee and Executive Committee.

Previous Experience
Brinson Partners/UBS Global Asset Management
Trinity Ventures, Ltd.
Boston Consulting Group

Academic
Dartmouth College, BA
Stanford University, MBA, Arjay Miller Scholar